Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by BostonGene

BostonGene to Participate in Pathology Visions 2024, Driving Collaborative Advancements in Digital Pathology and Regulatory Science
From BostonGene
Via Business Wire
BostonGene to Showcase Innovative Precision Medicine Strategies for Non-Small Cell Lung Cancer at the Advancing Precision Medicine Conference 2024
From BostonGene
Via Business Wire
Fujita Health University and BostonGene Expand Access to Genomic Cancer Testing with Tumor Portrait™ at Haneda Clinic
From BostonGene
Via Business Wire
BostonGene and Sarah Cannon Research Institute Collaborate to Accelerate the Development of Targeted Cancer Therapies and Improve Patient Outcomes
From BostonGene
Via Business Wire
BostonGene Announces Partnership with Takeda to Evaluate Immunotherapies Using AI-Powered Molecular Profiling
From BostonGene
Via Business Wire
BostonGene and Sylvester Comprehensive Cancer Center at the University of Miami Collaborate to Advance Care for Cancer Patients
From BostonGene
Via Business Wire
BostonGene Highlights Its AI-Powered Multiomics Platform at hubXchange’s Immuno-Oncology Xchange Boston 2024
From BostonGene
Via Business Wire
BostonGene Announces Seven Abstract Acceptances at the 2024 American Society of Clinical Oncology Annual Meeting
From BostonGene
Via Business Wire
BostonGene and the Medical College of Wisconsin Announce the Publication and Journal Cover Feature in Gastroenterology Highlighting Transcriptomic-Based Tumor Microenvironment Classification for Precision Medicine in Pancreatic Cancer
From BostonGene
Via Business Wire
BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
From BostonGene
Via Business Wire
BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients
From BostonGene
Via Business Wire
BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2024
From BostonGene
Via Business Wire
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider
From BostonGene
Via Business Wire
BostonGene Wins Four GlobalData’s Clinical Trials Arena Excellence Awards
From BostonGene
Via Business Wire
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell
From BostonGene
Via Business Wire
Frost & Sullivan Recognizes BostonGene with Frost & Sullivan’s Enabling Technology Leadership Award for Revolutionizing Precision Oncology Diagnostics
From BostonGene
Via Business Wire
BostonGene Bolsters Leadership Team to Accelerate Innovation and Growth
From BostonGene
Via Business Wire
BostonGene to Showcase Comprehensive Portfolio of Advanced Diagnostic Tools and Technologies at the 21st Japanese Society of Medical Oncology Annual Meeting
From BostonGene
Via Business Wire
BostonGene Demonstrates Benefits of Integrated Tumor Tissue and Blood Profiling at SLAS2024 International Conference and Exhibition
From BostonGene
Via Business Wire
BostonGene and Duke University Announce Master Collaboration Agreement
From BostonGene
Via Business Wire
GlobalData Names BostonGene Leading Innovator in AI-Driven Drug Repurposing
From BostonGene
Via Business Wire
BostonGene Announces Publication in Blood
From BostonGene
Via Business Wire
Sarcoma Oncology Center Leverages BostonGene’s AI-Driven Molecular and Immune Profiling Platform to Identify Novel Treatment Options for Patients with Advanced Cancers
From BostonGene
Via Business Wire
BostonGene Announces Ten Presentations at the 65th American Society of Hematology Annual Meeting & Exposition
From BostonGene
Via Business Wire
BostonGene to Present at the 2023 San Antonio Breast Cancer Symposium
From BostonGene
Via Business Wire
BostonGene Wins Fierce Life Sciences Innovation Award for AI-Driven Clinical Trials Matching Algorithm
From BostonGene
Via Business Wire
BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2023 Annual Meeting
From BostonGene
Via Business Wire
BostonGene and Weill Cornell Medicine to Showcase Poster Presentations on Transcriptome-based Tumor Microenvironment Classification for Advancement of Personalized Cancer Therapeutics at the 20th International Cancer Genome Consortium Scientific...
From BostonGene
Via Business Wire
LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial
From BostonGene
Via Business Wire
BostonGene Announces Poster Presentation at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
From BostonGene
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.